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Purpose
Hemorrhagic metastatic brain tumors are not rare, but little is known about the surgical outcome
following treatment. We conducted this study to determine the result of the surgical outcome
of hemorrhagic metastatic brain tumors.
Materials and Methods
From July 2001 to December 2008, 21 patients underwent surgery for hemorrhagic metastatic
brain tumors at our institution. 15 patients had lung cancer, 3 had hepatocellular carcinoma,
and the rest had rectal cancer, renal cell carcinoma, and sarcoma. 20 patients had macro-
scopic hemorrhage in the tumors, and one patient had intracerebral hemorrhage surrounding
the tumor. A retrospective clinical review was conducted focusing on the patterns of pre-
senting symptoms and signs, as well as local recurrence following surgery.
Results
Among 21 hemorrhagic brain metastases, local recurrence developed in two patients. The
12 month progression free survival rate was 86.1%. Mean time to progression was 20.8
months and median survival time after surgery was 11.7 months. 
Conclusion
The results of our study showed that hemorrhagic metastatic brain tumors rarely recurred
after surgery. Surgery should be considered as a good treatment option for hemorrhagic
brain metastasis, especially in cases with increased intracranial pressure or severe neuro-
logic deficits.
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Introduction
In pathological and radiological studies the frequency of spon-
taneous intracerebral hemorrhage (ICH) in intracranial neoplasms
ranges from 1.4 to 10% with an average of 2-3% [1-4]. In general,
any type of intracranial neoplasm can cause ICH, but the frequency
varies widely among different tumor types [1-4]. Fast growing and
highly vascularized neoplasms with an irregular and fragile vascular
architecture are most frequently associated with ICH [5,6]. Metastatic
tumors or malignant gliomas are the most common type of these
tumors. Hemorrhage was a complication in 14% of patients with
brain metastases compared to 0.8% of patients with gliomas [7].
Metastatic malignant melanoma bled in approximately 50% of the
cases, whereas metastatic adenocarcinoma, squamous carcinoma,
and anaplastic carcinoma had significantly lower bleeding rates [7].
There are several reports that have described the negative effects
of intratumoral hemorrhage on tumor control after stereotactic radio-
surgery [8-10]. Furthermore, most of these patients presented with
acute stroke-like symptoms and signs. Therefore, surgery could be a
more suitable treatment option in case of hemorrhagic metastasis
because surgery can relieve neurologic deficits immediately. Although
hemorrhage from metastatic brain tumors has often been observed,
there is no study to date that has addressed the effect of intratumoral
hemorrhage on surgical outcomes. To determine the result of surgical
outcomes of hemorrhagic metastatic brain tumors, we reviewed the
clinical records of patients treated with surgery for hemorrhagic
brain metastases at our institution retrospectively.Heon Yoo, et al_Hemorrhagic Metastatic Brain Tumors
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Materials and Methods
From July 2001 to December 2008, 228 metastatic brain tumor
surgeries were performed at our institution. Among them, 21
patients showed hemorrhagic metastatic brain tumors. Clinical data
and imaging studies of 21 hemorrhagic metastatic brain tumors were
reviewed retrospectively. All tumors were preoperatively examined
with computed tomography or magnetic resonance imaging (MRI).
Neuro-navigation-guided microsurgical excision was performed.
The resection status was determined according to the margin biopsy
and MRI performed within 48 hours after the craniotomy. Follow
up in our outpatient department included neurological examination
and contrast-enhanced cranial MRI every three months. The mean
follow up period was 12.6 months (range, 1 to 62 months) after
surgery. Immediate postoperative systemic chemotherapy was done
to control primary disease. Postoperative radiotherapy (RT) was
delayed until the recurrence of brain lesions, which was in accor-
dance with our policy. When primary disease was well controlled,
adjuvant RT was done immediately. Local and distant recurrence
and survival times after brain surgery were analyzed. Local recurrence
was defined as recurrence at the site of an original metastasis treated
by surgery, and distant recurrence was defined as recurrence at other
sites in the brain unrelated to the surgery. For survival analysis, we
used the Kaplan-Meier method. Survival time was calculated after
the day of brain surgery. 
Results
1 Clinical characteristics
During the study period, 228 patients received metastatic brain
tumor surgery. The primary diseases were lung cancer in 158 patients
(69.2%), breast cancer in 18 patients (7.9%), colorectal cancer in 17
patients (7.5%), liver and renal cancer in 10 patients (4.4%),
sarcoma and gynecologic cancer in 3 patients (1.3%), and stomach,
esophagus, and thyroid cancer in 2 patients (0.9%). Other three
patients were melanoma, testicular cancer, and unknown primary
cancer. Among them, 21 patients had hemorrhagic metastatic brain
tumors (9.2%). Patient characteristics are summarized in Table 1.
Sixteen patients (76.2%) were male, and five were female. The mean
age was 52.6 years (range, 25 to 72 years). Fifteen patients (71.4%)
had lung cancer, three patients (14.3%) had liver cancer, and the
others had colorectal cancer (4.8%), renal cancer (4.8%), and sarcoma
(4.8%). Twenty patients showed macroscopic hemorrhage in the
tumor and one patient showed macroscopic hemorrhage immediately
surrounding the tumor. All patients except one received chemo-
therapy. RT was done in 12 patients. Among them, preoperative RT
was done in two patients, immediate adjuvant postoperative RT was
done in six patients, and delayed RT was done in four patients after
local or distant recurrence developed. Fifteen patients had single
brain metastasis, and six patients had multiple metastases. Surgical
resection was done for only single symptomatic hemorrhagic lesions
among multiple brain metastases. All patients showed improved
neurological symptoms immediately after surgery. 
2 Local recurrence
Among 21 hemorrhagic brain metastases, local recurrence
developed only in two (9.5%) patients. The 12 month recurrence
free survival rates were 86.1%. One patient suffered from hepato-
cellular carcinoma. Tumor bleeding occurred 5 months after brain
Table 1. Characteristics of patients with hemorrhagic brain metastasis
Characteristics No. of patients (%)
Gender
Male 16 (76.2)
Female 5 (23.8)
Mean age (range, yr) 52.57 (25-72)
Primary organ
Lung 15 (71.4)
HCC 3 (14.3)
RCC 1 (4.8)
Rectum 1 (4.8)
Sarcoma 1 (4.8)
RPA class
I 2 (9.5)
II 9 (42.9)
III 10 (47.6)
Radiation therapy
+ 12 (57.1)
- 9 (42.9)
Chemotherapy
+ 20 (95.2)
- 1 (4.8)
Local recurrence
+ 2 (9.5)
- 19 (90.5)
Distant recurrence
+ 8 (38.1)
- 13 (61.9)
HCC, hepatocellular carcinoma; RCC, renal cell carcinoma; RPA, Recursive
Partitioning Analysis.
Table 2. Local and distant brain recurrence according to radiotherapy
Radiotherapy Fisher’s exact test
+ (n=9) - (n=12) p-value
Local recurrence - 8 11
+11 ĥ0.999
Distant recurrence - 4 8
+ 5 4 0.396Cancer Res Treat. 2011;43(2):102-107
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RT. Local recurrence occurred 10 months of surgery. A second
surgery was performed for the local recurrence, but 3 months later
the metastatic mass recurred. The patient expired 19 months after
initial brain surgery. The other patient who showed local recurrence
suffered from lung cancer. He showed repeated intra-tumoral hemo-
rrhage at one week intervals. He showed local and distant metastases
only 1 month after surgery. He also showed rapid progression of the
primary disease and expired 2 months after surgery.
Among 9 RT-naïve patients, one patient showed local recurrence.
Among 12 patients who were treated with RT, one patient showed
local recurrence. There was no significant difference in local
recurrence rate between RT-naïve and RT patients (Fisher’s exact
test, pĥ0.999) (Table 2).
3 Distant recurrence
Eight (38.1%) patients showed distant brain recurrence. Seven
patients suffered from lung cancer. One patient had renal cell
carcinoma. The median time to progression (TTP) was 11 months after
surgery. Twelve-month progression free survival rate was 39.7% (Fig. 1).
Among nine RT-naïve patients, five patients showed distant brain
recurrence (55.6%). However, among 12 patients who received RT,
four patients showed distant brain recurrence (33.3%), but there was
no statistical significance (Fisher’s exact test, p=0.396) (Table 2).
4 Overall survival
The median survival time was 11.7 months, and 12-month
survival rate was 48.2% (Fig. 2). Factors affecting overall survival
were analyzed in univariate and multivariate analysis using Cox
regression model (Table 3). Prognostic factors that were analyzed
included primary tumor origin, tumor size, patient age, number of
lesions, time to develop brain metastases, extent and status of
primary and systemic disease, Recursive Partitioning Analysis class,
and history of RT. There were no significant differences in overall
survival among different primary cancers (Fig. 3). Statistically
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Fig. 2. Overall survival curve of hemorrhagic brain metastasis.
Factor
Univariate analysis Hazard ratio Multivariate analysis Hazard ratio
(p-value) (95% CI) (p-value) (95% CI)
Primary tumor origin 0.561 1.443 (0.420, 4.959) NA
Tumor size 0.264 1.026 (0.981, 1.073) NA
Age 0.031 0.941 (0.890, 0.995) 0.805
Multiplicity of tumor 0.297 2.055 (0.530, 7.963) NA
Period of brain metastasis 0.233 0.976 (0.937, 1.016) NA
Primary site control 0.001 13.070 (2.691, 63.481) 0.002 40.117 (3.773, 426.594)
3.633 (0.223, 59.188)
RPA class 0.323 0.632 (0.707, 5.724) 0.081 0.196 (0.038, 1.023)
1.635 (0.198, 13.486)
Radio therapy 0.320 1.785 (0.570, 5.590) 0.201
Table 3. Factors affecting overall survival in univariate and multivariate survival analysis (Cox regression model)
CI, confidence interval; NA, not assessed; RPA, Recursive Partitioning Analysis.
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Fig. 1. Distant recurrence free survival curve of hemorrhagic brain
metastasis.Heon Yoo, et al_Hemorrhagic Metastatic Brain Tumors
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significant prognostic factors were patient age (p=0.031) and primary
disease control (p=0.001) in univariate analysis. However, in multi-
variate analysis, the only significant prognostic factor was primary
disease control (p=0.002).
Discussion
It is not unusual for intracranial neoplasms to undergo spon-
taneous hemorrhage, regardless of whether they are intrinsic brain
tumors or metastatic lesions. Prospective series indicate that brain
tumors present as hemorrhagic lesions 2-3% of the time [2]. Similarly,
in prospective series, a presenting spontaneous intra-cerebral hemo-
rrhage can be associated with an intracranial tumor approximately
7% of the time [2]. In Kondziolka’s series, intra-tumoral hemorrhage
C B A
F E D
Fig. 4. Illustrative case. A 55-yr-old male with non small cell lung cancer with hemorrhagic brain metastasis showed no local recurrence 49 mo
after surgery without postoperative radiation therapy. However, multiple small distant metastases had developed. (A) Pre-operative non-contrast
enhanced computed tomography (CT). (B) Pre-operative contrast-enhanced CT. (C) Pre-operative T2-weighted magnetic resonance imaging
(MRI). (D) Pre-operative T1-weighted MRI. (E) Pre-operative gadolinium enhanced T1-weighted MRI. (F) Gadolinium enhanced T1-weighted
MRI after 49 mo after surgery.
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Fig. 3. Overall survival curve of hemorrhagic brain metastasis based
on primary cancers.Cancer Res Treat. 2011;43(2):102-107
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developed in 24% (36/147) of metastatic brain tumors [1]. Twenty-
five percent (9/36) of the patients showed macroscopic hemorrhage
[1]. However, only 2.7% of metastatic tumors exhibited acute
symptoms [1]. According to Maiuri et al. [7], metastases are the
most frequent cause of tumor-related ICH followed by glioblastoma.
Among the metastases, malignant melanomas are most commonly
observed. Metastases of choriocarcinoma represent a special feature
because they directly erode cerebral vessels causing hemorrhage
[11,12]. Because recurrent ICH occurs in all types of tumors, several
authors have stressed the importance of complete tumor resection
[4,13]. Furthermore, there are several reports that describe the negative
effect of intra-tumoral hemorrhage on tumor control after stereotactic
radiosurgery [8-10]. Therefore, surgery may be a more suitable
treatment option in case of hemorrhagic metastasis.
Various theories for the etiology of intra-tumoral hemorrhage
have been proposed previously. These include endothelial prolife-
ration with vascular obliteration, vessel compression and/or distortion
due to rapid tumor growth, vessel necrosis, invasion of vessel walls
by the tumor, and increased venous pressure associated with increased
intracranial pressure [14-17]. Common histological features of
tumors that bled include tumor necrosis as well as the vascular changes
of vessel-wall hyalinization, degeneration or necrosis of vessel
walls, thrombosis, the presence of many thin-walled vessels, and
ruptured vessels [1]. Recently, Jung et al. [18], reported that vascular
endothelial growth factor and matrix metalloproteinases have a
pathophysiological role in metastatic brain tumor-associated intra-
cerebral hemorrhage. The goal of surgery for brain metastases is
local disease control that results in stabilization or improvement of
clinical symptoms. Local recurrences occur despite the best standard
therapies. In studies of surgery and external beam radiation therapy,
the recurrence rate at the site of surgery was reported to be 10% to
34% [19-22]. The local recurrence rate of a brain metastasis is likely
to increase with prolonged survival time in cancer patients due to the
advent of highly effective biological and other related targeted
therapies. However, there is no study that addressed the effect of
intra-tumoral hemorrhage on local recurrence following surgery. 
Local recurrence following resection is believed to develop from
microscopic, infiltrative tumor cells left behind at the time of
surgery, beyond the circumference of the tumor removed. In a recent
study reported from M. D. Anderson, there was a higher risk of local
recurrence of brain metastasis with piecemeal resection than with en
bloc resection, and tumor volume was also a negative prognostic
factor [23]. In their report, tumors that were removed by piecemeal
resection were significantly larger [23]. These two negative prognostic
factors associated with local recurrence may be inter-related [23].
Previously, we reported that microscopic total resection of brain
metastases that included removal of tumor cells infiltrating adjacent
brain parenchyma to a depth of 5 mm at the tumor circumference,
with resection margins pathologically confirmed to be free of tumor
cells, significantly reduced local recurrence [24]. In this study, there
were only two local recurrence episodes among 21 hemorrhagic
brain metastases patients. Hemorrhagic tumors usually have a good
dissection plane, so it is relatively easy to resect them completely.
Another possible reason for the lower local recurrence rate may be
disruption of the blood supply to the tumor and subsequent tumor
cell necrosis when intra-tumor hemorrhage occurs.
Conclusion
The results of this study showed that hemorrhagic metastasis
rarely recurred after surgery regardless of treatment with adjuvant
therapy. Further prospective studies for a larger number of patients are
required to determine adjuvant therapy after surgery for hemorrhagic
brain metastases.
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